Fibrinogen concentrate + Fresh Frozen Plasma
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair
Conditions
Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair
Trial Timeline
Jun 1, 2010 → —
NCT ID
NCT00994045About Fibrinogen concentrate + Fresh Frozen Plasma
Fibrinogen concentrate + Fresh Frozen Plasma is a approved stage product being developed by CSL for Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair. The current trial status is completed. This product is registered under clinical trial identifier NCT00994045. Target conditions include Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair.
What happened to similar drugs?
0 of 1 similar drugs in Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair were approved
Approved (0) Terminated (0) Active (1)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00994045 | Approved | Completed |
Competing Products
2 competing products in Coagulopathy in Patients Having Thoraco-Abdominal Aneurysm Repair
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Camostat Mesylate + Microcrystalline Cellulose, NF | Ono Pharmaceutical | Phase 1/2 | 24 |
| Beriplex® P/N (Kcentra) + Fresh frozen plasma | CSL | Phase 3 | 40 |